Suppr超能文献

体外受精-胚胎移植中促排卵期间血清孕酮升高的影响。

The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.

作者信息

Huang J C, Jackson K V, Hornstein M D, Ginsburg E S

机构信息

Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

J Assist Reprod Genet. 1996 Sep;13(8):617-24. doi: 10.1007/BF02069639.

Abstract

OBJECTIVE

Our purpose was to determine whether elevated progesterone (P) during ovulation induction in IVF-ET cycles is a poor prognostic factor for achieving pregnancy.

DESIGN

We retrospectively reviewed 672 consecutive IVF-ET cycles in which ovulation was performed using luteal LA downregulation and hMG.

SETTING

The ART program at the Brigham & Women's Hospital, a tertiary care institution, was the study setting.

MAIN OUTCOME MEASURES

Patients were divided into groups by serum P levels at baseline, on stimulation day 5, on the day of hCG injection, and, on the day after hCG injection and the following parameters were compared: duration of luteal LA treatment, number of ampoules of hMG used, estradiol (E2) levels, number of follicles > or = 12 mm, number of follicles > or = 15 mm, number of oocytes, number of normal embryos, number of polyspermic embryos, fertilization rate, implantation rate, and clinical and ongoing/live birth pregnancy rates.

RESULTS

Based on serum P level, patients were divided into three groups: Group I, < or = 0.31 ng/ml (conversion factor to SIU, 3.180); Group II, and > 0.3 and < 1.0 ng/ml and Group III, > or = 1.0 ng/ml. Measureable P at baseline was associated with a higher cancellation rate, but no difference in other cycle outcome parameters. Progesterone > 0.31 ng/ml on stimulation day 5 was associated with a higher fertilization rate in Groups II and III, but there was no difference in the clinical pregnancy or ongoing/live birth rates among the three groups. Based on P on the day of hCG administration, Groups II and III had significantly more oocytes and higher fertilization rates than did Group I, however, clinical pregnancy and ongoing/live birth rates were not significantly different. On the day after hCG, there was a trend toward a higher clinical pregnancy rate in Group III, which had younger patients, better follicular recruitment, and more embryos than Groups I or II, but these differences did not reach statistical significance.

CONCLUSIONS

Serum P > 0.31 ng/ml during ovulation induction reflects good follicular recruitment, and is not a predictor of IVF outcome.

摘要

目的

我们的目的是确定体外受精 - 胚胎移植(IVF - ET)周期中诱导排卵期间孕酮(P)升高是否是妊娠结局不良的预后因素。

设计

我们回顾性分析了连续672个IVF - ET周期,这些周期采用黄体期长效激动剂(LA)降调节和人绝经期促性腺激素(hMG)进行排卵诱导。

设置

研究在三级医疗机构布莱根妇女医院的辅助生殖项目中进行。

主要观察指标

根据基线、刺激第5天、注射人绒毛膜促性腺激素(hCG)当天、hCG注射后一天的血清P水平将患者分组,并比较以下参数:黄体期LA治疗持续时间、hMG使用安瓿数、雌二醇(E2)水平、直径≥12mm的卵泡数、直径≥15mm的卵泡数、卵母细胞数、正常胚胎数、多精受精胚胎数、受精率、着床率以及临床妊娠率和持续/活产妊娠率。

结果

根据血清P水平,患者分为三组:第一组,≤0.31ng/ml(换算为国际单位的转换因子为3.180);第二组,>0.3且<1.0ng/ml;第三组,≥1.0ng/ml。基线时可检测到的P与较高的取消率相关,但在其他周期结局参数方面无差异。刺激第5天孕酮>0.31ng/ml与第二组和第三组较高的受精率相关,但三组的临床妊娠率或持续/活产率无差异。根据hCG给药当天的P水平,第二组和第三组的卵母细胞明显多于第一组,受精率也更高,然而,临床妊娠率和持续/活产率无显著差异。hCG注射后一天,第三组有临床妊娠率升高的趋势,该组患者较年轻,卵泡募集更好,胚胎比第一组或第二组更多,但这些差异未达到统计学意义。

结论

诱导排卵期间血清P>0.31ng/ml反映卵泡募集良好,并非IVF结局的预测指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验